E Fund Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

E Fund Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,544	Closed	-$334K	–	390
2024 Q1	$334K	Buy	9,544 +4,032	+73%	+$147K	0.02%	261
2023 Q4	$209K	Buy	+5,512	New	+$118K	0.01%	274
2023 Q1	–	Sell	-10,315	Closed	-$254K	–	359
2022 Q4	$254K	Buy	+10,315	New	+$303K	0.02%	257

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

E Fund Management's INBX Position: Q2 2024 in Review

E Fund Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 9,544 shares — an estimated $334K sold.

E Fund Management first reported a position in INBX in Q4 2022 and held it in 3 quarters. The position peaked at $334K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

E Fund Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
E Fund Management sold 9,544 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $334K.
E Fund Management first reported a position in Inhibrx, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
E Fund Management's Inhibrx, Inc. Common Stock position peaked at $334K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.